AMY MCCORD: Open Payments
NPI 1134610777 · CARMI, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 50 payments from 9 companies in 2025. Trend: 2023 $319 · 2024 $385 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $270 |
| Novo Nordisk Inc | 9 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Viatris Specialty LLC | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: QULIPTA, Rybelsus, VRAYLAR, CAPLYTA, UBRELVY, MOUNJARO, BREZTRI, Cologuard Collection Kit.
Industry payments across IL — which companies pay providers there.
